We are live on ! Find out more
ADVM

Adverum Biotechnologies
ADVM

Delisted

ADVM was delisted on the 8th of December, 2025.

Back to rankings

86 hedge funds and large institutions have $121M invested in Adverum Biotechnologies in 2018 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 26 increasing their positions, 24 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

148% more call options, than puts

Call options by funds: $129K | Put options by funds: $52K

8% more repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 24

0.6% more ownership

Funds ownership: 5.51% → 6.11% (+0.6%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

15% less funds holding

Funds holding: 101 → 86 (-15)

50% less first-time investments, than exits

New positions opened: 14 | Existing positions closed: 28

55% less capital invested

Capital invested by funds: $269M → $121M (-$148M)

Holders
86
Holders Change
-15
Holders Change %
-14.85%
% of All Funds
1.92%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
14
Increased
26
Reduced
24
Closed
28
Calls
$129K
Puts
$52K
Net Calls
+$77K
Net Calls Change
-$2.37M

Top Buyers

Rank Fund Capital Flow
1
RI
RTW Investments
New York
+$24.7M
2
EAM
Eventide Asset Management
Massachusetts
+$4.66M
3
UBS Group
UBS Group
Switzerland
+$3.46M
4
BlackRock
BlackRock
New York
+$3.07M
5
Citadel Advisors
Citadel Advisors
Florida
+$2.84M

Top Sellers

Rank Fund Capital Flow
1
MSU
Mizuho Securities USA
New York
-$60.5M
2
DCM
Driehaus Capital Management
Illinois
-$11.3M
3
CHP
Castle Hook Partners
New York
-$6.55M
4
RSCM
Rock Springs Capital Management
Maryland
-$5.45M
5
Alkeon Capital Management
Alkeon Capital Management
New York
-$4.95M
Name Holding Trade Value Shares
Change 		Change in
Stake
Morgan Stanley
26
Morgan Stanley
New York
$566K -$185K -4,537 -20%
Axa
27
Axa
France
$533K – – –
Ameriprise
28
Ameriprise
Minnesota
$505K +$651K +16,011 New
Point72 Asset Management
29
Point72 Asset Management
Connecticut
$479K +$618K +15,194 New
Deutsche Bank
30
Deutsche Bank
Germany
$379K -$312K -7,674 -39%
RPAM
31
Rhenman & Partners Asset Management
Sweden
$377K -$140K -3,430 -22%
TA
32
Teachers Advisors
New York
$371K – – –
Charles Schwab
33
Charles Schwab
California
$359K – – –
TCIM
34
TIAA CREF Investment Management
New York
$338K -$5.37K -132 -1%
OAM
35
Oxford Asset Management
United Kingdom
$326K +$106K +2,611 +34%
Assenagon Asset Management
36
Assenagon Asset Management
Luxembourg
$317K +$409K +10,056 New
Jacobs Levy Equity Management
37
Jacobs Levy Equity Management
New Jersey
$313K +$159K +3,904 +65%
AG
38
Algert Global
California
$296K +$59.6K +1,465 +18%
Millennium Management
39
Millennium Management
New York
$281K -$310K -7,613 -46%
Connor, Clark & Lunn Investment Management (CC&L)
40
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$278K -$278K -6,832 -44%
California State Teachers Retirement System (CalSTRS)
41
California State Teachers Retirement System (CalSTRS)
California
$264K – – –
Goldman Sachs
42
Goldman Sachs
New York
$258K +$275K +6,750 +461%
RhumbLine Advisers
43
RhumbLine Advisers
Massachusetts
$245K +$93.9K +2,308 +42%
AQR Capital Management
44
AQR Capital Management
Connecticut
$244K -$251K -6,169 -44%
SFM
45
Sphera Funds Management
Israel
$200K -$47.3K -1,164 -16%
State of Wisconsin Investment Board
46
State of Wisconsin Investment Board
Wisconsin
$179K – – –
Invesco
47
Invesco
Georgia
$147K +$26.4K +648 +16%
California Public Employees Retirement System
48
California Public Employees Retirement System
California
$145K -$249K -6,131 -57%
New York State Common Retirement Fund
49
New York State Common Retirement Fund
New York
$138K – – –
Bank of America
50
Bank of America
North Carolina
$128K +$107K +2,633 +186%
1
2
3 4 5

ADVM Hedge Fund Activity: Q4 2018 in Review

86 of the 4,489 institutional investors tracked by Wall St. Rank reported a position in Adverum Biotechnologies (ADVM) for Q4 2018, worth a combined $121M — down 55% from $269M a quarter earlier.

Sellers outnumbered buyers: 28 funds closed out of ADVM and 14 opened new positions — a net loss of 14 holders — while 24 trimmed existing stakes and 26 added.

The largest buyer was RTW Investments, adding an estimated $24.7M. The largest seller was Mizuho Securities USA, exiting entirely with an estimated $60.5M sold.

  • 86 institutional investors held Adverum Biotechnologies (ADVM) as of Q4 2018, down from 101 in Q3 2018.
  • Funds reported $121M of Adverum Biotechnologies stock for Q4 2018, down 55% quarter-over-quarter.
  • 14 funds opened new Adverum Biotechnologies positions in Q4 2018 and 28 closed out, a net change of -14 holders.
  • The largest Adverum Biotechnologies buyer in Q4 2018 was RTW Investments, an estimated $24.7M added.
  • The largest Adverum Biotechnologies seller in Q4 2018 was Mizuho Securities USA, an estimated $60.5M sold.

Based on aggregated 13F filings for Q4 2018.